Apervita, Inc. announced that the DARTNet Institute has joined the growing list of health leaders to leverage Apervita to create and distribute affordable evidence-based analytics to primary care practices for population health management.
DARTNet is a not-for-profit research support organization, collaborating with one of the largest groups of practice-based research networks. The DARTNet collaborative has built a national data collection network for electronic health records, claims and patient-reported outcomes to assist with research, quality improvement and clinical care. As part of its partnership with Apervita, the DARTNet Chronic Disease Screening & Management Protocols have been made executable so they can be used by primary care physician (PCP) practices across the country.
“This partnership with Apervita allows physicians to access and deploy DARTNet’s analytics in a way that is relevant to managing the early onset of chronic disease,” explained Guillermo Rocha, MD, one of DARTNet’s participating physicians. “Many PCPs feel overwhelmed with the amount of patient data they have to deal with today. Protocols that process complex data have helped identify risks and support us in adhering to best practices.”
Chronic Kidney Disease (CKD) and End-Stage Renal Disease are increasing in prevalence across the United States, and contribute to growing healthcare costs, according to the National Kidney Foundation (NKF). Evidence from the NKF Kidney Disease Outcomes Quality Initiative (KDOQI) suggests that the early detection and management of CKD and its associated co-morbidities, such as hypertension, dyslipidemia, cardiovascular disease and bone disease, can improve patient outcomes by delaying disease progression and improving quality of life. With evidence-based protocols, DARTNet provides PCPs with tools that facilitate adherence to the recent guidelines set forth by the NKF KDOQI.
“Distributing our analytics through the Apervita platform facilitates the adoption of primary care protocols. The Apervita marketplace enables PCP subscription to these analytics and the delivery of insight back into workflow, bridging the gap between identifying populations at risk and applying protocols to help reduce patient risk,” said Dr. Wilson Pace, CEO of DARTNet Institute. “With Apervita, DARTNet’s analytics, such as measures and protocols, can now be accessed and used to support the delivery of care to patients, help mitigate patient disease risks, while also simplifying reporting requirements.”
“The DARTNet Institute is an example of an institution that creates innovative analytics for primary care physicians, yet until today, there have been hurdles for this knowledge to be adopted. Apervita is enabling DARTNet and other organizations to make their evidence-based analytics widely available to clinicians,” said Paul Magelli, chief executive officer of Apervita. “By partnering with Apervita, the DARTNet Institute’s analytics become executable and more easily made available at the point of practice.”